OP0100 Superior Gains in Bone Mineral Density and Estimated Strength at The Hip for Romosozumab Compared with Teriparatide in Women with Postmenopausal Osteoporosis Transitioning from Bisphosphonate Therapy: Results of The Phase 3 Open-Label Structure Study

Abstract

BackgroundIn a phase 2 study, treatment with romosozumab significantly increased bone mass in women with low bone mineral density (BMD).ObjectivesTo report the results of STRUCTURE, a phase 3 study evaluating...